Two Sigma Investments Portfolio holdings
AUM
$55.5B
1-Year Return
27.18%
This Quarter Return
+5.29%
1 Year Return
+27.18%
3 Year Return
+82.36%
5 Year Return
+135.75%
10 Year Return
+365.6%
AUM
$43.5B
AUM Growth
-$729M
(-1.7%)
Cap. Flow
-$2.62B
Cap. Flow
% of AUM
-6.02%
Top 10 Holdings %
Top 10 Hldgs %
7.47%
Holding
3,532
New
471
Increased
1,128
Reduced
1,380
Closed
418
Top Buys
| 1 |
Amazon
AMZN
|
+$260M |
| 2 |
Tesla
TSLA
|
+$242M |
| 3 |
Intel
INTC
|
+$237M |
| 4 |
Applied Materials
AMAT
|
+$217M |
| 5 |
Airbnb
ABNB
|
+$216M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$292M |
| 2 |
Applovin
APP
|
+$288M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$262M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
Micron Technology
MU
|
+$217M |
Sector Composition
| 1 | Technology | 16.95% |
| 2 | Healthcare | 14.19% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHMI
2826
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $110K | ﹤0.01% |
41,621
-253,693
| -86% | -$670K |
|
|
RZLV
2827
Rezolve AI PLC Ordinary Shares
RZLV
$1.52B
| $110K | ﹤0.01% |
+28,748
| New | +$110K |
|
2828
Fortress Biotech
FBIO
$115M
| $109K | ﹤0.01% |
+54,054
| New | +$109K |
|
2829
Blink Charging
BLNK
$129M
| $107K | ﹤0.01% |
+77,117
| New | +$107K |
|
2830
PDS Biotechnology
PDSB
$57.8M
| $107K | ﹤0.01% |
65,732
+48,132
| +273% | +$78.5K |
|
|
CLPR
2831
Clipper Realty
CLPR
$69.8M
| $103K | ﹤0.01% |
+22,495
| New | +$103K |
|
2832
Nuvectis Pharma
NVCT
$160M
| $100K | ﹤0.01% |
18,570
-8,215
| -31% | -$44.4K |
|
2833
Vodafone
VOD
$28.1B
| $99.5K | ﹤0.01% |
11,718
-59,582
| -84% | -$506K |
|
2834
ChargePoint
CHPT
$235M
| $98.8K | ﹤0.01% |
4,615
-27,688
| -86% | -$592K |
|
2835
Caesarstone
CSTE
$50.5M
| $97.2K | ﹤0.01% |
22,879
-20,986
| -48% | -$89.2K |
|
2836
Genelux
GNLX
$138M
| $97.2K | ﹤0.01% |
41,177
-18,446
| -31% | -$43.5K |
|
2837
Arbutus Biopharma
ABUS
$886M
| $96.4K | ﹤0.01% |
29,486
-240
| -0.8% | -$785 |
|
|
OTLY
2838
Oatly Group
OTLY
$513M
| $95.7K | ﹤0.01% |
7,217
+5,316
| +280% | +$70.5K |
|
2839
Metagenomi
MGX
$69.1M
| $95.6K | ﹤0.01% |
26,471
-59,135
| -69% | -$213K |
|
2840
AEye
LIDR
$106M
| $94.9K | ﹤0.01% |
74,736
+61,437
| +462% | +$78K |
|
2841
Lloyds Banking Group
LYG
$66.4B
| $94K | ﹤0.01% |
34,572
| – | – |
|
2842
Celularity
CELU
$62.7M
| $93.4K | ﹤0.01% |
+44,914
| New | +$93.4K |
|
2843
Karyopharm Therapeutics
KPTI
$53.8M
| $93.2K | ﹤0.01% |
9,186
+3,457
| +60% | +$35.1K |
|
2844
American Battery Technology Co
ABAT
$211M
| $92.9K | ﹤0.01% |
37,750
+10,756
| +40% | +$26.5K |
|
2845
1-800-Flowers.com
FLWS
$326M
| $91.9K | ﹤0.01% |
11,249
| – | – |
|
2846
Liberty Latin America Class C
LILAK
$1.54B
| $90.7K | ﹤0.01% |
14,300
| – | – |
|
2847
Verrica Pharmaceuticals
VRCA
$47.7M
| $89.9K | ﹤0.01% |
12,844
+1,316
| +11% | +$9.21K |
|
2848
Cumberland Pharmaceuticals
CPIX
$50.9M
| $89.2K | ﹤0.01% |
37,649
+18,271
| +94% | +$43.3K |
|
|
INZY
2849
DELISTED
Inozyme Pharma
INZY
| $88.4K | ﹤0.01% |
+31,924
| New | +$88.4K |
|
2850
Acacia Research
ACTG
$304M
| $87.6K | ﹤0.01% |
20,175
-7,065
| -26% | -$30.7K |
|